Therapeutic Vaccines Market Segmentation by Type of Vaccines {Addiction, Infectious Disease, Autoimmune Disease, and Neurological Disease Vaccines); and by Technology (Autologous, and Allogeneic Vaccines) - Global Demand Analysis & Opportunity Outlook 2029

Global Therapeutic Vaccines Market Highlights 2020-2029

The global therapeutic vaccines market is anticipated to witness a moderate CAGR during the forecast period, i.e., 2021-2029. Factors such as the growing prevalence of chronic and infectious diseases globally, such as rabies, hepatitis, allergies, breast, and lung cancers among others, coupled with the increasing funding and favorable regulatory policies from the government of nations for promoting research and advancements in the development of therapeutic vaccines, and the growing number of vaccine manufacturers who are working on the development of advanced vaccines are anticipated to drive the market growth in the coming years. According to the statistics by the World Health Organization (WHO), around 17.9 million people died from cardiovascular diseases (CVDs) in the year 2016. On the other hand, there was an increase in premature mortality from diabetes by 5% between 2000 and 2016. Additionally, increasing need for the development of therapeutic vaccines for the ongoing COVID-19 pandemic is also anticipated to contribute to the market growth. 

The market is segmented by type of vaccines into addiction, infectious disease, autoimmune disease, and neurological disease vaccines. Among these segments, the autoimmune disease segment is projected to hold the largest market share by the end of 2021. The growth of the segment can be attributed to the growing awareness about autoimmune diseases amongst individuals, especially the elderly population, who possesses a high risk to the disease, coupled with the high prevalence of the autoimmune diseases amongst individuals, and the increasing research and development for the development of autoimmune disease drugs.

Get more information on this report: Download Sample PDF

Global Therapeutic Vaccines Market Regional Synopsis

Regionally, the global therapeutic vaccines market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Among these regions, the market in North America is projected to hold the largest market share by the end of 2029. The growth of the market in the region can be attributed to the presence of a strong healthcare network in the region, along with the increasing expenditure of the government for the advancements in medical and healthcare technologies.

The global therapeutic vaccines market is further classified on the basis of region as follows:

• North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
• Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
• Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
• Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis.
• Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Market Segmentation

Our in-depth analysis of the global therapeutic vaccines market includes the following segments:

By Type of Vaccines

• Addiction Vaccines
  • Cocaine
  • Nicotine
  • Others
• Infectious Disease Vaccines
  • HIV/AIDS
  • Hepatitis C
  • Others
• Autoimmune Disease Vaccines
  • Cancer Vaccines
    • Cancer Vaccines Approved for Use
    • Cancer Vaccines in Development
  • Diabetes (Type 1)
    • TNFaKinoid
    • Tovaxin
    • Diamyd (RHGAD65)
    • BHT-3021
  • Others
• Neurological Disease Vaccines
  • Parkinson’s Disease
  • Others

By Technology

• Autologous Vaccines
• Allogeneic Vaccines

Growth Drivers

• Increasing Funding of the Government for the Development of Novel Vaccines
• Increasing Prevalence of Diseases

Challenges

• Stringent Regulatory Framework of the Government

Top Featured Companies Dominating the Market

• SCM Lifescience
  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Developments
  • Regional Presence
  • SWOT Analysis
• Agenus Inc.
• Kuros Biosciences
• CureVac AG
• CEL-SCI
• Ipsen Pharma
• Cell Culture Company, LLC
• AFFiRiS AG
• Celldex Therapeutics
• Bavarian Nordic